.

BioPharmaceutical Business Intelligence

  • Analyze global market entry opportunities
  • Identify first generic entrants
  • Drug patents in 130+ countries

Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

Serving leading biopharmaceutical companies globally:

UBS
Cantor Fitzgerald
McKesson
Julphar
Argus Health
Healthtrust
QuintilesIMS
Mallinckrodt
AstraZeneca
Novartis

Generated: December 14, 2017

DrugPatentWatch Database Preview

HYDROFLUMETHIAZIDE Drug Profile

« Back to Dashboard

Which patents cover Hydroflumethiazide, and what generic alternatives are available?

Hydroflumethiazide is a drug marketed by Par Pharm, Watson Labs, and Usl Pharma. and is included in six NDAs.

The generic ingredient in HYDROFLUMETHIAZIDE is hydroflumethiazide; reserpine. There are two drug master file entries for this compound. Additional details are available on the hydroflumethiazide; reserpine profile page.

US Patents and Regulatory Information

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Patent Submitted Product Substance Delist Req. Exclusivity Expiration
Par PharmHYDROFLUMETHIAZIDEhydroflumethiazideTABLET;ORAL088850-001May 31, 1985DISCNNoNo► Subscribe► Subscribe► Subscribe► Subscribe
Usl PharmaHYDROFLUMETHIAZIDE AND RESERPINEhydroflumethiazide; reserpineTABLET;ORAL088195-001Oct 26, 1983DISCNNoNo► Subscribe► Subscribe► Subscribe► Subscribe
Watson LabsHYDROFLUMETHIAZIDEhydroflumethiazideTABLET;ORAL088031-001Apr 6, 1983DISCNNoNo► Subscribe► Subscribe► Subscribe► Subscribe
Watson LabsHYDROFLUMETHIAZIDEhydroflumethiazideTABLET;ORAL088528-001Aug 15, 1984DISCNNoNo► Subscribe► Subscribe► Subscribe► Subscribe
Watson LabsHYDROFLUMETHIAZIDE AND RESERPINEhydroflumethiazide; reserpineTABLET;ORAL088110-001Mar 22, 1983DISCNNoNo► Subscribe► Subscribe► Subscribe► Subscribe
Watson LabsHYDROFLUMETHIAZIDE AND RESERPINEhydroflumethiazide; reserpineTABLET;ORAL088127-001Mar 22, 1983DISCNNoNo► Subscribe► Subscribe► Subscribe► Subscribe
This preview shows a limited data set
Subscribe for full access, or try a Trial

Export unavailable in trial.
Subscribe for complete access.

« Back to Dashboard

For more information try a trial or see the plans and pricing

Serving leading biopharmaceutical companies globally:

Baxter
Johnson and Johnson
Merck
Queensland Health
Federal Trade Commission
McKinsey
Moodys
US Army
Chubb
Cipla

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.

Copyright 2002-2017 thinkBiotech LLC
ISSN: 2162-2639

Secure SSL Encrypted
Privacy and Cookies
Terms & Conditions

Follow DrugPatentWatch:

botpot